{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:07:05Z","timestamp":1790554025555,"version":"4.1.0"},"reference-count":30,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2011,1,31]],"date-time":"2011-01-31T00:00:00Z","timestamp":1296432000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Movement Disorders"],"published-print":{"date-parts":[[2011,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Lesch\u2010Nyhan disease (LND) is characterized by dystonia, cognitive abnormalities, and self\u2010injurious behavior. No effective therapies are available. LND is associated with a presynaptic dopaminergic deficit, but the reported effects of dopamine replacement therapy are conflicting. The current prospective open\u2010label study assesses the effects of levodopa on both neurological and behavioral features of LND. All 6 study participants discontinued levodopa early, due to lack of effect and sometimes worsening of motor function. The results provide important clues for pathophysiological mechanisms and suggestions for future treatment options. \u00a9 2011 Movement Disorder Society<\/jats:p>","DOI":"10.1002\/mds.23478","type":"journal-article","created":{"date-parts":[[2011,1,31]],"date-time":"2011-01-31T08:46:16Z","timestamp":1296463576000},"page":"746-749","source":"Crossref","is-referenced-by-count":37,"title":["Levodopa is not a useful treatment for Lesch\u2010Nyhan disease"],"prefix":"10.1002","volume":"26","author":[{"given":"Jasper E.","family":"Visser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Schretlen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bastiaan R.","family":"Bloem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyder A.","family":"Jinnah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,1,31]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(64)90104-4"},{"key":"e_1_2_5_3_2","first-page":"2537","volume-title":"The metabolic and molecular bases of inherited disease","author":"Jinnah HA","year":"2001"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awl056"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1017\/S135561770177703X"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-8749.1995.tb15017.x"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198111053051902"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-973462"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.11.5539"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199606133342403"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(89)90659-8"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-510X(88)90099-8"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.14-03-01164.1994"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2007.01.010"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4684-5104-7_31"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.21786"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(74)92990-0"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410230507"},{"key":"e_1_2_5_19_2","first-page":"43","article-title":"Clinical, post\u2010mortem, biochemical and therapeutic observations on the Lesch\u2010Nyhan syndrome with particular reference to the Neurological manifestations","volume":"51","author":"Watts RW","year":"1982","journal-title":"Q J Med"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02369904"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.35.1.73"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0173(99)00094-6"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awp172"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-7634(96)00040-1"},{"key":"e_1_2_5_25_2","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0022-3565(25)21630-5","article-title":"Behavioral differences between neonatal and adult 6\u2010hydroxydopamine\u2010treated rats to dopamine agonists: relevance to neurological symptoms in clinical syndromes with reduced brain dopamine","volume":"231","author":"Breese GR","year":"1984","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(09)70287-X"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.21475"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.3171\/jns.2003.98.2.0414"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.10095"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.21723"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neucli.2005.12.004"}],"container-title":["Movement Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fmds.23478","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fmds.23478","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/movementdisorders.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/mds.23478","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T09:25:22Z","timestamp":1760952322000},"score":1,"resource":{"primary":{"URL":"https:\/\/movementdisorders.onlinelibrary.wiley.com\/doi\/10.1002\/mds.23478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,31]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["10.1002\/mds.23478"],"URL":"https:\/\/doi.org\/10.1002\/mds.23478","archive":["Portico"],"relation":{},"ISSN":["0885-3185","1531-8257"],"issn-type":[{"value":"0885-3185","type":"print"},{"value":"1531-8257","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,31]]}}}